Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy Immuron is seeking a partner to support ...
(Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year landmark Phase 1b data from the fully enrolled C-800-01 cohort evaluating botensilimab (BOT), an Fc-enhanced ...
The Agentic AI Foundation has taken in its first project since launch. CTO Manik Surtani explains why an open, portable ...
Gentleman's Pursuits on MSN
GMC Jimmy revival: The off-roader GM should have built years ago
The GMC Jimmy Is Coming Back — and This Time, It Might Actually Be Worth Getting Excited About There is a particular kind of ...
As this week sees the World Cup field cut from 32 to 16, we're wondering what the biggest issue is for each team still in the ...
Here is why I stopped trusting standard note apps with my personal diaries and hosted my own instead. I've tried a plethora ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants ...
Objectives Elective non-emergent surgical wait times have increased across countries such as Canada, straining operating room ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results